XML 15 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Revenue $ 21,457 $ 101,630
Cost of revenue 23,112 55,798
Gross profit (1,655) 45,832
Operating expenses    
Selling, general, and administrative 2,039,328 1,674,206
Research and development 50,818 24,455
Impairment of goodwill 8,134,000 10,918,000
Total operating expenses 10,224,146 12,616,661
Loss from operations (10,225,801) (12,570,829)
Other (expense) income    
Interest expense (2,244) (223,592)
Change in fair value of subscription agreement liability – related party 3,319,000
Change in fair value of contingent warrant liabilities 1,612 (9,795)
Change in fair value of Series D Derivative Liability 3,955,778
Change in fair value of Series E Derivative Liability 2,072,590
Gain on forgiveness of accounts payable 944,694
Other income (loss) (16,810) (5,363)
Total other income (loss) 6,010,926 4,024,944
Loss before income taxes (4,214,875) (8,545,885)
Income tax benefit
Net loss (4,214,875) (8,545,885)
Deemed dividend Series C preferred stock (1,170,091)
Net loss applicable to common stockholders $ (4,214,875) $ (9,715,976)
Net loss per share, basic (in Dollars per share) $ (6.71) $ (227.25)
Net loss per share, diluted (in Dollars per share) $ (6.71) $ (227.25)
Weighted average number of common shares outstanding, basic (in Shares) 628,528 42,755
Weighted average number of common shares outstanding, diluted (in Shares) 628,528 42,755
Other comprehensive income (loss)    
Net loss $ (4,214,875) $ (8,545,885)
Foreign currency translation (210,172) 141,048
Change in pension benefit obligation (30,779)
Total comprehensive loss $ (4,425,047) $ (8,435,616)